Acrolein inhibits NADH-linked mitochondrial enzyme activity: Implications for Alzheimer's disease
- 164 Downloads
In Alzheimer's disease (AD) brain increased lipid peroxidation and decreased energy utilization are found. Mitochondria membranes contain a significant amount of arachidonic and linoleic acids, precursors of lipid peroxidation products, 4-hydroxynonenal (HNE) and 2-propen-1-al (acrolein), that are extremely reactive. Both alkenals are increased in AD brain. In this study, we examined the effects of nanomolar levels of acrolein on the activities pyruvate dehydrogenase (PDH) and α-ketoglutarate dehydrogenase (KGDH), both reduced nicotinamide adenine dinucleotide (NADH)-linked mitochondrial enzymes. Acrolein decreased PDH and KGDH activities significantly in a dose-dependent manner. Using high performance liquid chromatography coupled to mass spectrometry (HPLCMS), acrolein was found to bind lipoic acid, a component in both the PDH and KGDH complexes, most likely explaining the loss of enzyme activity. Acrolein also interacted with oxidized nicotinamide adenine dinucleotide (NAD+) in such a way as to decrease the production of NADH. Acrolein, which is increased in AD brain, may be partially responsible for the dysfunction of mitochondria and loss of energy found in AD brain by inhibition of PDH and KGDH activities, potentially contributing to the neurodegeneration in this disorder.
KeywordsAcrolein Pyruvate dehydrogenase Lipoic acid α-Ketoglutarate dehydrogenase Mitochondria
Unable to display preview. Download preview PDF.
- Blass JP (2000) The mitochondrial spiral: an adequate cause of dementia in Alzheimer syndrome.Ann. NY Acad. Sci. USA 924, 170–183.Google Scholar
- Castegna A, M Aksenov, M Aksenova, V Thongboonkerd, JB Klein, WM Pierce, R Booze, WR Markesbery and DA Butterfield (2002) Proteomic identification of oxidatively modified proteins in Alzheimer's disease brain. Part i: creatine kinase BB, glutamine synthase, and ubiquitin carboxy-terminal hydrolase L-1.Free Radic. Biol. Med. 33, 562–571.PubMedCrossRefGoogle Scholar
- Hensley K, N Hall, R Subramaniam, P Cole, M Harris, M Aksenov, M Aksenova, SP Gabbita, JF Wu, JM Carney, M Lovell, WR Markesbery and DA Butterfield (1995) Brain regional correspondence between Alzheimer's disease histopathology and biomarkers of protein oxidation.J. Neurochem. 65, 2146–2156.PubMedGoogle Scholar
- Pocernich CB, AL Cardin, CL Racine, CM Lauderback and DA Butterfield (2001) Glutathione elevation and its protective role in acrolein-induced protein damage in synaptosomal membranes: relevance to brain lipid peroxidation in neurodegenerative disease.Neurochem. Int. 39, 141–149.PubMedCrossRefGoogle Scholar